114 related articles for article (PubMed ID: 23581458)
1. A randomized, placebo-controlled, crossover study of an herbal preparation containing Vernonia cinerea in the treatment of type 2 diabetes.
Bin Sayeed MS; Mostofa AG; Ferdous FM; Islam MS
J Altern Complement Med; 2013 Sep; 19(9):767-71. PubMed ID: 23581458
[TBL] [Abstract][Full Text] [Related]
2. A double blind randomised placebo controlled cross over study of a herbal preparation containing Salacia reticulata in the treatment of type 2 diabetes.
Jayawardena MH; de Alwis NM; Hettigoda V; Fernando DJ
J Ethnopharmacol; 2005 Feb; 97(2):215-8. PubMed ID: 15707755
[TBL] [Abstract][Full Text] [Related]
3. Ayurvedic Herbal Preparation Supplementation Does Not Improve Metabolic Health in Impaired Glucose Tolerance Subjects; Observations from a Randomised Placebo Controlled Trial.
Esser D; Matualatupauw J; de Vos RCH; Wehrens R; van der Stappen J; van der Meer I; Afman LA
Nutrients; 2021 Jan; 13(1):. PubMed ID: 33477443
[TBL] [Abstract][Full Text] [Related]
4. The effect of Momordica charantia capsule preparation on glycemic control in type 2 diabetes mellitus needs further studies.
Dans AM; Villarruz MV; Jimeno CA; Javelosa MA; Chua J; Bautista R; Velez GG
J Clin Epidemiol; 2007 Jun; 60(6):554-9. PubMed ID: 17493509
[TBL] [Abstract][Full Text] [Related]
5. Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial.
Derosa G; Cicero AF; Gaddi A; Ragonesi PD; Fogari E; Bertone G; Ciccarelli L; Piccinni MN
Clin Ther; 2004 May; 26(5):744-54. PubMed ID: 15220018
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of a herbal drug of Coccinia grandis (Linn.) Voigt in patients with type 2 diabetes mellitus: A double blind randomized placebo controlled clinical trial.
Wasana KGP; Attanayake AP; Weerarathna TP; Jayatilaka KAPW
Phytomedicine; 2021 Jan; 81():153431. PubMed ID: 33352495
[TBL] [Abstract][Full Text] [Related]
7. Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.
Roberts VL; Stewart J; Issa M; Lake B; Melis R
Clin Ther; 2005 Oct; 27(10):1535-47. PubMed ID: 16330290
[TBL] [Abstract][Full Text] [Related]
8. The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus.
Rosenblatt S; Miskin B; Glazer NB; Prince MJ; Robertson KE;
Coron Artery Dis; 2001 Aug; 12(5):413-23. PubMed ID: 11491207
[TBL] [Abstract][Full Text] [Related]
9. Combination insulin/glyburide therapy in type II diabetes mellitus. Effects on lipoprotein metabolism and glucoregulation.
Falko JM; Osei K
Am J Med; 1985 Sep; 79(3B):92-101. PubMed ID: 3931467
[TBL] [Abstract][Full Text] [Related]
10. Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study Group.
Einhorn D; Rendell M; Rosenzweig J; Egan JW; Mathisen AL; Schneider RL
Clin Ther; 2000 Dec; 22(12):1395-409. PubMed ID: 11192132
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of green cardamom on serum SIRT1, glycemic indices and triglyceride levels in patients with type 2 diabetes mellitus: a randomized double-blind placebo controlled clinical trial.
Aghasi M; Koohdani F; Qorbani M; Nasli-Esfahani E; Ghazi-Zahedi S; Khoshamal H; Keshavarz A; Sotoudeh G
J Sci Food Agric; 2019 Jun; 99(8):3933-3940. PubMed ID: 30701554
[TBL] [Abstract][Full Text] [Related]
12. Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes.
Rosenstock J; Fonseca VA; Garvey WT; Goldberg RB; Handelsman Y; Abby SL; Lai YL; Jin X; Misir S; Nagendran S; Jones MR
Endocr Pract; 2010; 16(4):629-40. PubMed ID: 20634175
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus.
Herz M; Johns D; Reviriego J; Grossman LD; Godin C; Duran S; Hawkins F; Lochnan H; Escobar-Jiménez F; Hardin PA; Konkoy CS; Tan MH
Clin Ther; 2003 Apr; 25(4):1074-95. PubMed ID: 12809958
[TBL] [Abstract][Full Text] [Related]
14. The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.
Robinson AC; Burke J; Robinson S; Johnston DG; Elkeles RS
Diabetes Care; 1998 May; 21(5):701-5. PubMed ID: 9589227
[TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy and safety of canagliflozin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise: findings from the 52-week CANTATA-M study.
Stenlöf K; Cefalu WT; Kim KA; Jodar E; Alba M; Edwards R; Tong C; Canovatchel W; Meininger G
Curr Med Res Opin; 2014 Feb; 30(2):163-75. PubMed ID: 24073995
[TBL] [Abstract][Full Text] [Related]
16. Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.
Derosa G; Cicero AF; D'Angelo A; Gaddi A; Ciccarelli L; Piccinni MN; Salvadeo SA; Pricolo F; Ferrari I; Gravina A; Ragonesi PD
Clin Ther; 2006 May; 28(5):679-88. PubMed ID: 16861090
[TBL] [Abstract][Full Text] [Related]
17. Safety profile and metabolic effects of 14 days of treatment with DIO-902: results of a phase IIa multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in patients with type 2 diabetes mellitus.
Schwartz SL; Rendell M; Ahmann AJ; Thomas A; Arauz-Pacheco CJ; Welles BR
Clin Ther; 2008 Jun; 30(6):1081-8. PubMed ID: 18640464
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes.
Jayagopal V; Albertazzi P; Kilpatrick ES; Howarth EM; Jennings PE; Hepburn DA; Atkin SL
Diabetes Care; 2002 Oct; 25(10):1709-14. PubMed ID: 12351466
[TBL] [Abstract][Full Text] [Related]
19. Effects of bee propolis supplementation on glycemic control, lipid profile and insulin resistance indices in patients with type 2 diabetes: a randomized, double-blind clinical trial.
Samadi N; Mozaffari-Khosravi H; Rahmanian M; Askarishahi M
J Integr Med; 2017 Mar; 15(2):124-134. PubMed ID: 28285617
[TBL] [Abstract][Full Text] [Related]
20. Improved glycemic control in patients with advanced type 2 diabetes mellitus taking Urtica dioica leaf extract: a randomized double-blind placebo-controlled clinical trial.
Kianbakht S; Khalighi-Sigaroodi F; Dabaghian FH
Clin Lab; 2013; 59(9-10):1071-6. PubMed ID: 24273930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
